Abbott Laboratories (ABT) 48.32 $ABT
Abbott Labs Increases In Price But Doesn't Have Great Growth Prospects
Abba's Aces - at Seeking Alpha - Sun Apr 26, 12:28AM CDT
ABT: 48.32 (-0.14)
Mylan 'Raises' Perrigo Bid, But Teva Buzz Builds
at Investor's Business Daily - Fri Apr 24, 4:51PM CDT
Seeking to avoid being a takeover itself, Mylan (MYL) raised its offer for Perrigo (PRGO), which promptly rejected the bid, saying the proposal was worse than before. Generic drugmaker Mylan bid $60 cash and 2.2 Mylan shares for each share of...
ABT: 48.32 (-0.14), PRGO: 192.89 (-8.74), WBA: 85.98 (-0.71), WMT: 79.84 (+0.66), MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16)
Nurturing Your Portfolio With Mead Johnson
DividendDeveloper - Seeking Alpha - Fri Apr 24, 2:45PM CDT
Quick Background : Mead Johnson Nutrition (NYSE: MJN ) is a global pediatric nutrition company. The company's brands include the flagship Enfa family (including the well-known Enfamil), Nutramigen, Cal-C-Tose, and ChocoMilk. The company was founded...
ABT: 48.32 (-0.14), MJN: 97.94 (+1.53), PFE: 35.27 (-0.09)
Dale's Super 7 Dividend Aristocrat And Achievers Portfolio Core
Dale Roberts - at Seeking Alpha - Thu Apr 23, 5:45PM CDT
MMM: 158.99 (-0.67), GE: 26.80 (-0.05), MON: 118.46 (+0.97), NKE: 100.95 (-0.16), UTX: 116.16 (-1.10), BLK: 372.98 (+1.05), XOM: 86.97 (-0.57), WMT: 79.84 (+0.66), VIG: 81.59 (+0.22), PEP: 95.17 (-0.56), JNJ: 101.08 (+0.62), XLP: 49.19 (+0.01), SPY: 211.65 (+0.49), TRP: 47.13 (+0.12), IBM: 169.78 (-0.46), QCOM: 68.24 (-0.10), EOG: 96.72 (-1.55), LOW: 73.16 (-0.21), CAT: 84.60 (-0.19), OXY: 79.77 (-0.27), AAPL: 130.28 (+0.61), FDX: 169.95 (-0.15), KO: 40.89 (-0.06), ABT: 48.32 (-0.14), WBA: 85.98 (-0.71), MED: 31.52 (+0.25), TXN: 54.73 (+0.01), BCE: 44.92 (-0.03), CVS: 101.58 (+0.70), ENB: 53.83 (+0.12), AIG: 56.99 (+0.24), TU: 35.16 (-0.03), BRK.B: 142.09 (-0.34), CL: 69.17 (-0.05)
DepoMed Set To Grow On 'Transformative' Nucynta Deal
at Investor's Business Daily - Thu Apr 23, 3:16PM CDT
This is setting up to be a big year for specialty drugmaker DepoMed. After years of lumpy quarters driven by licensing deals with other drugmakers, DepoMed (DEPO) is coming into its own as an independent commercial pharma. It's developed or acquired...
ENDP: 93.27 (-0.81), ABT: 48.32 (-0.14), JNJ: 101.08 (+0.62), DEPO: 27.65 (+0.36)
Company News for April 23, 2015 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Apr 23, 9:10AM CDT
Companies in the News are: YUM,ANGI,ABT,CMG
ABT: 48.32 (-0.14), CMG: 637.50 (+1.90), ANGI: 6.16 (-0.24), YUM: 87.10 (+3.03)
Global Electrophysiology Market Report 2014-2020
M2 - Thu Apr 23, 6:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4wjt34/electrophysiology) has announced the addition of the "Electrophysiology Global Market Analysis - Forecast (2014-2020)" report to their offering. This report analyzes the global markets for Electrophysiology. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance North America (U.S., and Canada), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Analysis 4 Porters Five Force Analysis 5 Electrophysiology Market by Diagnostic Devices 5.1 X-ray Systems 5.2 Diagnostic Catheters 5.3 EMG 5.4 ECG 5.5 EEG 6 Electrophysiology Market by Therapeutic Devices 6.1 Cardiac Pacemakers 6.2 CRT 6.3 ICDs 6.4 Ablation Catheters 7 Geographical Segmentation 8 Vendor Landscaping 9 Company Profiles - Abbott Laboratories - Biotronik - Boston Scientific Corp. - C.R. Bard Inc. - Medtronic, Inc. - Siemens AG - St. Jude Medical Inc. For more information visit http://www.researchandmarkets.com/research/4w...physiology
BSX: 18.34 (-0.08), ABT: 48.32 (-0.14), BCR: 175.38 (-0.87), MDT: 77.61 (-0.89), STJ: 73.47 (-0.54)
Wall Street Breakfast: Where's The Value These Days?
Wall Street Breakfast - at Seeking Alpha - Thu Apr 23, 5:27AM CDT
CXO: 125.84 (-0.64), PZN: 9.25 (+0.05), OCR: 86.11 (-0.20), BTG: 1.55 (-0.03), HL: 3.04 (-0.06), AUQ: 3.43 (-0.11), SKX: 89.66 (+2.79), CNQ: 33.62 (-0.01), INTC: 32.08 (-0.27), GOOG: 565.06 (+18.06), RRC: 61.36 (-0.58), NOK: 7.76 (-0.09), UUUU: 5.30 (-0.12), PBR: 9.99 (+0.59), URRE: 1.41 (-0.05), KGC: 2.30 (-0.01), GSM: 21.17 (+0.17), DNN: 0.95 (-0.02), SLW: 19.16 (-0.19), EOG: 96.72 (-1.55), TMUS: 34.31 (-0.13), SIRI: 3.96 (+0.03), MA: 90.72 (-0.16), AEC: 28.45 (+0.04), HAR: 145.10 (-1.39), GOLD: 74.55 (-1.54), FB: 81.53 (-0.88), NCR: 28.88 (-1.01), AU: 10.65 (-0.47), IAG: 2.12 (-0.03), MCP: 0.99 (+0.15), BA: 148.40 (-1.47), AVL: 0.30 (+0.01), IWB: 118.66 (+0.17), NG: 3.58 (-0.04), NFX: 38.76 (+0.72), PXD: 174.10 (-1.06), OSN: 0.70 (-0.03), TXN: 54.73 (+0.01), FNV: 49.24 (-1.07), PAAS: 9.18 (-0.15), MCD: 98.74 (+1.74), RGLD: 62.30 (-1.76), MRO: 30.33 (-0.22), AUY: 3.83 (-0.10), NVS: 104.28 (-1.22), KMI: 44.34 (-0.23), DHI: 26.57 (+0.42), CCJ: 17.30 (+0.03), CLR: 51.35 (-1.25), GFI: 4.10 (-0.19), LVS: 55.25 (+0.13), REMX: 27.59 (+0.33), URZ: 1.25 (-0.04), SU: 33.06 (+0.08), T: 34.01 (-0.22), UEC: 2.31 (-0.09), ECA: 14.00 (-0.04), XLP: 49.19 (+0.01), GMO: 0.80 (-0.04), V: 67.48 (-0.24), EBAY: 59.20 (+0.31), EGO: 4.70 (-0.20), S: 5.27 (+0.03), BHP: 51.04 (+1.82), TRN: 28.70 (-4.66), QCOM: 68.24 (-0.10), ANGI: 6.16 (-0.24), URG: 1.04 (+0.01), GOOGL: 573.66 (+16.20), EMC: 26.50 (-0.09), TWC: 155.26 (+6.50), AGI: 6.71 (-0.11), XLF: 24.28 (-0.04), AAPL: 130.28 (+0.61), REE: 0.76 (-0.03), APC: 92.65 (-0.81), KO: 40.89 (-0.06), BAM: 55.58 (+0.03), AMZN: 445.10 (+55.11), ABT: 48.32 (-0.14), ABX: 12.52 (-0.12), NEM: 24.98 (+1.53), DB: 34.26 (+0.11), ASML: 107.16 (-1.53), XLV: 74.39 (-0.24), VSI: 42.98 (-0.15), BIDU: 216.90 (+4.62), ARRS: 35.76 (-1.54), LEU: 5.22 (+0.58), CMCSA: 59.64 (+0.41), SBGL: 8.64 (-0.72), GG: 19.01 (-0.51), BABA: 84.57 (+2.29)
Galt & Company Explains Innovative Approach to Increased Shareholder Value on Corporate Review
M2 - Thu Apr 23, 5:08AM CDT
The partners of Galt & Company have been associated with some of most notable corporate success stories of the last two decades, including those at Coca-Cola, Clorox, Gillette, Abbott Laboratories, BB&T, Alcan, MeadWestvaco and others. Scott Gillis, Co-founder and Senior Managing Director of Galt & Company, makes an extremely incisive observation during a recent appearance on Corporate Review. Gillis states, "While competition is greater than ever, we find that management misconceptions about what drives shareholder value and how to manage its growth, not competition, is the greatest impediment to improving shareholder value." Tune in on Bloomberg Asia Pacific (as pd. prog) on April 26, 2015 at 3:00pm HKT to learn more about Galt + Company. Check your local listings for airtimes.
ABT: 48.32 (-0.14), MWV: 47.50 (+0.41)
Abbott Labs' Q1 beats views
at Investor's Business Daily - Wed Apr 22, 5:22PM CDT
The medical-products giant reported EPS of 47 cents, up 12%, on sales of $4.9 bil, up 3%, with both results above analyst expectations. Abbott Laboratories (ABT) affirmed its full-year EPS guidance of $2.10$2.20. Leerink analyst Danielle Antalffy...
ABT: 48.32 (-0.14)
Abbott Laboratories (ABT) Stock Gained Today on Strong Earnings Beat
at The Street - Wed Apr 22, 3:55PM CDT
Abbott Laboratories (ABT) shares rose after the company beat analysts' first quarter earnings and revenue expectations today.
ABT: 48.32 (-0.14)
Omnicare reportedly exploring sale; trading halted
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 2:33PM CDT
ABT: 48.32 (-0.14), OCR: 86.11 (-0.20)
Abbott Laboratories' (ABT) CEO Miles White on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Apr 22, 1:26PM CDT
ABT: 48.32 (-0.14)
Abbott Labs (ABT) Beats on Q1 Earnings, View Reiterated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 12:18PM CDT
Abbott Laboratories (ABT) reported first-quarter 2015 earnings of 47 cents per share, up 38.2% from the year-ago quarter and beat the Zacks Consensus Estimate of 42 cents.
ABT: 48.32 (-0.14), VRX: 210.42 (+1.03), SHPG: 255.11 (-0.26), MYL: 76.06 (+2.37)
How to Trade the Market's Most-Active Stocks
at The Street - Wed Apr 22, 12:02PM CDT
Keep these stocks on your trading radar.
ABT: 48.32 (-0.14), MCD: 98.74 (+1.74), EMC: 26.50 (-0.09), BABA: 84.57 (+2.29)
Abbott Laboratories (ABT) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Wed Apr 22, 11:53AM CDT
The following Abbott Laboratories (ABT) conference call took place on April 22, 2015, 09:00 AM ET. This is a transcript of that earnings call:
ABT: 48.32 (-0.14)
St. Jude, Abbott Labs Beat Q1 Expectations
at Investor's Business Daily - Wed Apr 22, 9:54AM CDT
Two medical-product giants were rising in the stock market early Wednesday after beating first-quarter expectations. St. Jude Medical (STJ) jumped 6.5% to a new high above 73 after it reported earnings of 91 cents a share, up 6% from the year-earlier...
ABT: 48.32 (-0.14), STJ: 73.47 (-0.54), ABBV: 66.07 (+1.82)
Today's Unusual Social Activity Stock: Abbott Laboratories (ABT)
at The Street - Wed Apr 22, 8:48AM CDT
Trade-Ideas LLC identified Abbott Laboratories (ABT) as an unusual social activity candidate
ABT: 48.32 (-0.14)
Abbott Labs (ABT) Beats On Earnings in Q1 - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 8:22AM CDT
Abbott Labs (ABT) Beats On Earnings in Q1
ABT: 48.32 (-0.14)
Abbott Laboratories (ABT) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Apr 22, 7:55AM CDT
ABT: 48.32 (-0.14)
Abbott Labs Increases In Price But Doesn't Have Great Growth Prospects
Abba's Aces - at Seeking Alpha - Sun Apr 26, 12:28AM CDT
ABT: 48.32 (-0.14)
Mylan 'Raises' Perrigo Bid, But Teva Buzz Builds
at Investor's Business Daily - Fri Apr 24, 4:51PM CDT
Seeking to avoid being a takeover itself, Mylan (MYL) raised its offer for Perrigo (PRGO), which promptly rejected the bid, saying the proposal was worse than before. Generic drugmaker Mylan bid $60 cash and 2.2 Mylan shares for each share of...
ABT: 48.32 (-0.14), PRGO: 192.89 (-8.74), WBA: 85.98 (-0.71), WMT: 79.84 (+0.66), MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16)
Nurturing Your Portfolio With Mead Johnson
DividendDeveloper - Seeking Alpha - Fri Apr 24, 2:45PM CDT
Quick Background : Mead Johnson Nutrition (NYSE: MJN ) is a global pediatric nutrition company. The company's brands include the flagship Enfa family (including the well-known Enfamil), Nutramigen, Cal-C-Tose, and ChocoMilk. The company was founded...
ABT: 48.32 (-0.14), MJN: 97.94 (+1.53), PFE: 35.27 (-0.09)
Dale's Super 7 Dividend Aristocrat And Achievers Portfolio Core
Dale Roberts - at Seeking Alpha - Thu Apr 23, 5:45PM CDT
MMM: 158.99 (-0.67), GE: 26.80 (-0.05), MON: 118.46 (+0.97), NKE: 100.95 (-0.16), UTX: 116.16 (-1.10), BLK: 372.98 (+1.05), XOM: 86.97 (-0.57), WMT: 79.84 (+0.66), VIG: 81.59 (+0.22), PEP: 95.17 (-0.56), JNJ: 101.08 (+0.62), XLP: 49.19 (+0.01), SPY: 211.65 (+0.49), TRP: 47.13 (+0.12), IBM: 169.78 (-0.46), QCOM: 68.24 (-0.10), EOG: 96.72 (-1.55), LOW: 73.16 (-0.21), CAT: 84.60 (-0.19), OXY: 79.77 (-0.27), AAPL: 130.28 (+0.61), FDX: 169.95 (-0.15), KO: 40.89 (-0.06), ABT: 48.32 (-0.14), WBA: 85.98 (-0.71), MED: 31.52 (+0.25), TXN: 54.73 (+0.01), BCE: 44.92 (-0.03), CVS: 101.58 (+0.70), ENB: 53.83 (+0.12), AIG: 56.99 (+0.24), TU: 35.16 (-0.03), BRK.B: 142.09 (-0.34), CL: 69.17 (-0.05)
DepoMed Set To Grow On 'Transformative' Nucynta Deal
at Investor's Business Daily - Thu Apr 23, 3:16PM CDT
This is setting up to be a big year for specialty drugmaker DepoMed. After years of lumpy quarters driven by licensing deals with other drugmakers, DepoMed (DEPO) is coming into its own as an independent commercial pharma. It's developed or acquired...
ENDP: 93.27 (-0.81), ABT: 48.32 (-0.14), JNJ: 101.08 (+0.62), DEPO: 27.65 (+0.36)
Company News for April 23, 2015 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Apr 23, 9:10AM CDT
Companies in the News are: YUM,ANGI,ABT,CMG
ABT: 48.32 (-0.14), CMG: 637.50 (+1.90), ANGI: 6.16 (-0.24), YUM: 87.10 (+3.03)
Global Electrophysiology Market Report 2014-2020
M2 - Thu Apr 23, 6:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4wjt34/electrophysiology) has announced the addition of the "Electrophysiology Global Market Analysis - Forecast (2014-2020)" report to their offering. This report analyzes the global markets for Electrophysiology. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance North America (U.S., and Canada), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Analysis 4 Porters Five Force Analysis 5 Electrophysiology Market by Diagnostic Devices 5.1 X-ray Systems 5.2 Diagnostic Catheters 5.3 EMG 5.4 ECG 5.5 EEG 6 Electrophysiology Market by Therapeutic Devices 6.1 Cardiac Pacemakers 6.2 CRT 6.3 ICDs 6.4 Ablation Catheters 7 Geographical Segmentation 8 Vendor Landscaping 9 Company Profiles - Abbott Laboratories - Biotronik - Boston Scientific Corp. - C.R. Bard Inc. - Medtronic, Inc. - Siemens AG - St. Jude Medical Inc. For more information visit http://www.researchandmarkets.com/research/4w...physiology
BSX: 18.34 (-0.08), ABT: 48.32 (-0.14), BCR: 175.38 (-0.87), MDT: 77.61 (-0.89), STJ: 73.47 (-0.54)
Wall Street Breakfast: Where's The Value These Days?
Wall Street Breakfast - at Seeking Alpha - Thu Apr 23, 5:27AM CDT
CXO: 125.84 (-0.64), PZN: 9.25 (+0.05), OCR: 86.11 (-0.20), BTG: 1.55 (-0.03), HL: 3.04 (-0.06), AUQ: 3.43 (-0.11), SKX: 89.66 (+2.79), CNQ: 33.62 (-0.01), INTC: 32.08 (-0.27), GOOG: 565.06 (+18.06), RRC: 61.36 (-0.58), NOK: 7.76 (-0.09), UUUU: 5.30 (-0.12), PBR: 9.99 (+0.59), URRE: 1.41 (-0.05), KGC: 2.30 (-0.01), GSM: 21.17 (+0.17), DNN: 0.95 (-0.02), SLW: 19.16 (-0.19), EOG: 96.72 (-1.55), TMUS: 34.31 (-0.13), SIRI: 3.96 (+0.03), MA: 90.72 (-0.16), AEC: 28.45 (+0.04), HAR: 145.10 (-1.39), GOLD: 74.55 (-1.54), FB: 81.53 (-0.88), NCR: 28.88 (-1.01), AU: 10.65 (-0.47), IAG: 2.12 (-0.03), MCP: 0.99 (+0.15), BA: 148.40 (-1.47), AVL: 0.30 (+0.01), IWB: 118.66 (+0.17), NG: 3.58 (-0.04), NFX: 38.76 (+0.72), PXD: 174.10 (-1.06), OSN: 0.70 (-0.03), TXN: 54.73 (+0.01), FNV: 49.24 (-1.07), PAAS: 9.18 (-0.15), MCD: 98.74 (+1.74), RGLD: 62.30 (-1.76), MRO: 30.33 (-0.22), AUY: 3.83 (-0.10), NVS: 104.28 (-1.22), KMI: 44.34 (-0.23), DHI: 26.57 (+0.42), CCJ: 17.30 (+0.03), CLR: 51.35 (-1.25), GFI: 4.10 (-0.19), LVS: 55.25 (+0.13), REMX: 27.59 (+0.33), URZ: 1.25 (-0.04), SU: 33.06 (+0.08), T: 34.01 (-0.22), UEC: 2.31 (-0.09), ECA: 14.00 (-0.04), XLP: 49.19 (+0.01), GMO: 0.80 (-0.04), V: 67.48 (-0.24), EBAY: 59.20 (+0.31), EGO: 4.70 (-0.20), S: 5.27 (+0.03), BHP: 51.04 (+1.82), TRN: 28.70 (-4.66), QCOM: 68.24 (-0.10), ANGI: 6.16 (-0.24), URG: 1.04 (+0.01), GOOGL: 573.66 (+16.20), EMC: 26.50 (-0.09), TWC: 155.26 (+6.50), AGI: 6.71 (-0.11), XLF: 24.28 (-0.04), AAPL: 130.28 (+0.61), REE: 0.76 (-0.03), APC: 92.65 (-0.81), KO: 40.89 (-0.06), BAM: 55.58 (+0.03), AMZN: 445.10 (+55.11), ABT: 48.32 (-0.14), ABX: 12.52 (-0.12), NEM: 24.98 (+1.53), DB: 34.26 (+0.11), ASML: 107.16 (-1.53), XLV: 74.39 (-0.24), VSI: 42.98 (-0.15), BIDU: 216.90 (+4.62), ARRS: 35.76 (-1.54), LEU: 5.22 (+0.58), CMCSA: 59.64 (+0.41), SBGL: 8.64 (-0.72), GG: 19.01 (-0.51), BABA: 84.57 (+2.29)
Galt & Company Explains Innovative Approach to Increased Shareholder Value on Corporate Review
M2 - Thu Apr 23, 5:08AM CDT
The partners of Galt & Company have been associated with some of most notable corporate success stories of the last two decades, including those at Coca-Cola, Clorox, Gillette, Abbott Laboratories, BB&T, Alcan, MeadWestvaco and others. Scott Gillis, Co-founder and Senior Managing Director of Galt & Company, makes an extremely incisive observation during a recent appearance on Corporate Review. Gillis states, "While competition is greater than ever, we find that management misconceptions about what drives shareholder value and how to manage its growth, not competition, is the greatest impediment to improving shareholder value." Tune in on Bloomberg Asia Pacific (as pd. prog) on April 26, 2015 at 3:00pm HKT to learn more about Galt + Company. Check your local listings for airtimes.
ABT: 48.32 (-0.14), MWV: 47.50 (+0.41)
Abbott Labs' Q1 beats views
at Investor's Business Daily - Wed Apr 22, 5:22PM CDT
The medical-products giant reported EPS of 47 cents, up 12%, on sales of $4.9 bil, up 3%, with both results above analyst expectations. Abbott Laboratories (ABT) affirmed its full-year EPS guidance of $2.10$2.20. Leerink analyst Danielle Antalffy...
ABT: 48.32 (-0.14)
Abbott Laboratories (ABT) Stock Gained Today on Strong Earnings Beat
at The Street - Wed Apr 22, 3:55PM CDT
Abbott Laboratories (ABT) shares rose after the company beat analysts' first quarter earnings and revenue expectations today.
ABT: 48.32 (-0.14)
Omnicare reportedly exploring sale; trading halted
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 2:33PM CDT
ABT: 48.32 (-0.14), OCR: 86.11 (-0.20)
Abbott Laboratories' (ABT) CEO Miles White on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Apr 22, 1:26PM CDT
ABT: 48.32 (-0.14)
Abbott Labs (ABT) Beats on Q1 Earnings, View Reiterated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 12:18PM CDT
Abbott Laboratories (ABT) reported first-quarter 2015 earnings of 47 cents per share, up 38.2% from the year-ago quarter and beat the Zacks Consensus Estimate of 42 cents.
ABT: 48.32 (-0.14), VRX: 210.42 (+1.03), SHPG: 255.11 (-0.26), MYL: 76.06 (+2.37)
How to Trade the Market's Most-Active Stocks
at The Street - Wed Apr 22, 12:02PM CDT
Keep these stocks on your trading radar.
ABT: 48.32 (-0.14), MCD: 98.74 (+1.74), EMC: 26.50 (-0.09), BABA: 84.57 (+2.29)
Abbott Laboratories (ABT) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Wed Apr 22, 11:53AM CDT
The following Abbott Laboratories (ABT) conference call took place on April 22, 2015, 09:00 AM ET. This is a transcript of that earnings call:
ABT: 48.32 (-0.14)
St. Jude, Abbott Labs Beat Q1 Expectations
at Investor's Business Daily - Wed Apr 22, 9:54AM CDT
Two medical-product giants were rising in the stock market early Wednesday after beating first-quarter expectations. St. Jude Medical (STJ) jumped 6.5% to a new high above 73 after it reported earnings of 91 cents a share, up 6% from the year-earlier...
ABT: 48.32 (-0.14), STJ: 73.47 (-0.54), ABBV: 66.07 (+1.82)
Today's Unusual Social Activity Stock: Abbott Laboratories (ABT)
at The Street - Wed Apr 22, 8:48AM CDT
Trade-Ideas LLC identified Abbott Laboratories (ABT) as an unusual social activity candidate
ABT: 48.32 (-0.14)
Abbott Labs (ABT) Beats On Earnings in Q1 - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 8:22AM CDT
Abbott Labs (ABT) Beats On Earnings in Q1
ABT: 48.32 (-0.14)
Abbott Laboratories (ABT) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Apr 22, 7:55AM CDT
ABT: 48.32 (-0.14)
